Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 343

Migraine

The Nerivio device developed by Theranica Bioelectronics is worn on the upper arm to stimulate the body's neural pathway and fight migraine pain. (Courtesy)
August 29, 2022, 7:15 pm
Israeli startup Theranica, maker of migraine-zapping device, nabs $45m investment
Financing part of ongoing Series C round as company readies for commercial expansion in US
By Ricky Ben-David
Still from 'Out of My Head': Emma retreats to her darkened room as a migraine descends. (Maya Edelman)
January 18, 2021, 12:53 am
For world’s 1 billion migraine sufferers, COVID a major headache, new film shows
Now streaming, documentary ‘Out of My Head’ on debilitating neurological disease coincides with worsening of condition for many during past year’s pandemic lockdowns
By Renee Ghert-Zand
Jamie Magrill
January 28, 2020, 3:36 pm
Jamie Magrill
Innovating the migraine: the good, the bad, and the ugly
New innovative technologies, both pharmacological and non-pharmacological, are in development in Israel and around the world; we can only hope a solution is just around the corner
The Nerivio device developed by Theranica Bioelectronics is worn on the upper arm to stimulate the body's neural pathway and fight migraine pain. (Courtesy)
December 19, 2019, 11:07 am
Israeli migraine-busting device saluted as 2020 ‘game changer’
Netanya-based startup Theranica chosen in category of ‘electro-charged therapeutics’ by New York data firm CB Insights
By Shoshanna Solomon
A general view of TEVA Pharmaceutical Industries in Jerusalem, Israel, October 11, 2013. (Yonatan Sindel/Flash90)
September 16, 2018, 11:38 am
Teva shares rally as FDA approves troubled drugmaker’s migraine treatment
Ajovy seen as key to helping firm reverse fortunes as sales decline for flagship drug Copaxone for multiple sclerosis; competition expected to arrive soon
By Shoshanna Solomon
An Israeli worker walks by the offices of Israeli pharmaceutical company Teva Industries in Jerusalem, October 11, 2013. (Yonatan Sindel/Flash90)
July 9, 2017, 3:00 pm
Pharma giant Teva looks to steady ship with new CEO in coming weeks
Chief will not be Israeli but someone with ‘top class pharma experience,’ says Chaim Hurvitz, whose family is Teva’s largest private shareholder
By Shoshanna Solomon
A general view of TEVA Pharmaceutical Industries in Jerusalem, Israel, October 11, 2013. (Yonatan Sindel/Flash90)
June 11, 2017, 5:53 pm
Teva shares rise in Tel Aviv as migraine results buoy investors
Drug is expected to lessen headache for pharma firm, which is facing stiff competition for its flagship anti-MS treatment Copaxone
By Shoshanna Solomon
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.